US-based InterMune acquired by Swiss pharmaceutical firm – Newsday


TODAYonline
US-based InterMune acquired by Swiss pharmaceutical firm
Newsday
BERLIN – Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune Inc., a California-based developer of treatments for lung diseases. The companies have reached an agreement under which Roche will acquire …
Roche buys US biotech firm InterMune for £5bnBBC News
Roche to Buy Drug Maker InterMune for $8.3 BillionNew York Times
Roche To Buy US Biotech Firm InterMune For $US8.3 BillionBusiness Insider Australia
Yahoo!7 News -Wall Street Journal
all 62 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd